Clinical Trials Logo

Colorecal Neoplasms clinical trials

View clinical trials related to Colorecal Neoplasms.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT00506571 Recruiting - Secondary Clinical Trials

Phase II Study of Irinotecan,Oxaliplatin Plus TS-1 in Untreated Metastatic Colorectal Cancer

TIROX2
Start date: July 2007
Phase: Phase 2
Study type: Interventional

Patients will be treated with irinotecan (150 mg/m2) followed by oxaliplatin (85 mg/m2) on day 1 and S-1 (80 mg/m2/day) from day 1 to 14 every 3 weeks. Patients will receive up to a planned treatment of maximum 12 cycles of chemotherapy. Response assessment will be performed every 2 cycles of chemotherapy.